| Alcohol consumption in response to the COVID-19 pandemic in the United States C Barbosa, AJ Cowell, WN Dowd Journal of Addiction Medicine 15 (4), 341-344, 2021 | 404 | 2021 |
| Prescription drug monitoring programs, nonmedical use of prescription drugs, and heroin use: Evidence from the National Survey of Drug Use and Health MM Ali, WN Dowd, T Classen, R Mutter, SP Novak Addictive behaviors 69, 65-77, 2017 | 183 | 2017 |
| Effect of increased alcohol consumption during COVID‐19 pandemic on alcohol‐associated liver disease: a modeling study J Julien, T Ayer, EB Tapper, C Barbosa, WN Dowd, J Chhatwal Hepatology 75 (6), 1480-1490, 2022 | 123 | 2022 |
| Substance use disorder treatment admissions and state-level prenatal substance use policies: Evidence from a national treatment database KB Kozhimannil, WN Dowd, MM Ali, P Novak, J Chen Addictive behaviors 90, 272-277, 2019 | 85 | 2019 |
| The cost‐effectiveness of brief intervention versus brief treatment of Screening, Brief Intervention and Referral to Treatment (SBIRT) in the United States C Barbosa, A Cowell, W Dowd, J Landwehr, A Aldridge, J Bray Addiction 112, 73-81, 2017 | 60 | 2017 |
| Screening, brief intervention, and referral to treatment in the emergency department: an examination of health care utilization and costs JL Pringle, DK Kelley, SM Kearney, A Aldridge, W Dowd, W Johnjulio, ... Medical Care 56 (2), 146-152, 2018 | 47 | 2018 |
| The mental health consequences of nonmedical prescription drug use among adolescents MM Ali, D Dean Jr, R Lipari, WN Dowd, AP Aldridge, SP Novak J Ment Health Policy Econ 18 (1), 3-15, 2015 | 45 | 2015 |
| Forecasting the Economic Burden of Cardiovascular Disease and Stroke in the United States Through 2050: A Presidential Advisory From the American Heart Association DS Kazi, MSV Elkind, A Deutsch, WN Dowd, P Heidenreich, O Khavjou, ... Circulation, 2024 | 41 | 2024 |
| The relative impact of brief treatment versus brief intervention in primary health‐care screening programs for substance use disorders A Aldridge, W Dowd, J Bray Addiction 112, 54-64, 2017 | 41 | 2017 |
| Return on investment of a work–family intervention: Evidence from the work, family, and health network C Barbosa, JW Bray, WN Dowd, MJ Mills, P Moen, B Wipfli, R Olson, ... Journal of occupational and environmental medicine 57 (9), 943-951, 2015 | 35 | 2015 |
| Alcohol consumption during the first year of the Covid-19 pandemic in the United States: results from a nationally representative longitudinal survey C Barbosa, WN Dowd, A Barnosky, KJ Karriker-Jaffe Journal of Addiction Medicine 17 (1), e11-e17, 2023 | 30 | 2023 |
| Forecasting the burden of cardiovascular disease and stroke in the United States through 2050—prevalence of risk factors and disease: a presidential advisory from the American … KEJ Maddox, MSV Elkind, HJ Aparicio, Y Commodore-Mensah, ... Circulation 150 (4), e65-e88, 2024 | 29 | 2024 |
| Forecasting the Burden of Cardiovascular Disease and Stroke in the United States Through 2050—Prevalence of Risk Factors and Disease: A Presidential Advisory From the American … KE Joynt Maddox, MSV Elkind, HJ Aparicio, Y Commodore-Mensah, ... Circulation, 2024 | 29 | 2024 |
| Sustaining SBIRT in the wild: simulating revenues and costs for Screening, Brief Intervention and Referral to Treatment programs AJ Cowell, WN Dowd, MJ Mills, JM Hinde, JW Bray Addiction 112, 101-109, 2017 | 29 | 2017 |
| Cost of screening, brief intervention, and referral to treatment in health care settings C Barbosa, AJ Cowell, J Landwehr, W Dowd, JW Bray Journal of Substance Abuse Treatment 60, 54-61, 2016 | 29 | 2016 |
| Program-and service-level costs of seven screening, brief intervention, and referral to treatment programs JW Bray, E Mallonee, W Dowd, A Aldridge, AJ Cowell, J Vendetti Substance abuse and rehabilitation, 63-73, 2014 | 28 | 2014 |
| The relationship between end‐of‐treatment alcohol use and subsequent healthcare costs: do heavy drinking days predict higher healthcare costs? AP Aldridge, GA Zarkin, WN Dowd, JW Bray Alcoholism: clinical and experimental research 40 (5), 1122-1128, 2016 | 25 | 2016 |
| The impact of the abuse-deterrent reformulation of extended-release OxyContin on prescription pain reliever misuse and heroin initiation C Wolff, WN Dowd, MM Ali, C McClellan, A Meinhofer, L Glos, R Mutter, ... Addictive behaviors 105, 106268, 2020 | 20 | 2020 |
| A time and motion study of Screening, Brief Intervention, and Referral to Treatment implementation in health‐care settings AJ Cowell, WN Dowd, J Landwehr, C Barbosa, JW Bray Addiction 112, 65-72, 2017 | 19 | 2017 |
| Modeling the impact of COVID‐19 pandemic‐driven increases in alcohol consumption on health outcomes and hospitalization costs in the United States C Barbosa, WN Dowd, SJ Neuwahl, J Rehm, S Imtiaz, GA Zarkin Addiction 118 (1), 48-60, 2023 | 16 | 2023 |